Skip to main content
. 2020 Nov 23;11:577927. doi: 10.3389/fneur.2020.577927

Figure 5.

Figure 5

Ablation of GSDMD improves neurological outcome post I/R injury. (A) CBF in the MCAO modeling. n = 5. (B–D) Blood glucose (B), blood gas (C), and body temperature (D) of the mice before and after MCAO modeling. n = 5. (E,F) Representative images of TTC staining in four sequential brain slices from WT and gsdmd−/− mice. n = 5. (G) Neurological recovery was evaluated by mNSS on days 1, 7, 14, 21, and 28 post MCAO/R. n = 12. (H,I) Immunohistochemical staining of brain tissue on day 1 post MCAO/R. n = 5. **P < 0.01, ***P < 0.001, vs. the WT group. GSDMD, gasdermin D; I/R, ischemia reperfusion; MCAO, middle cerebral artery occlusion; CBF, cerebral blood flow; mNSS, modified neurological severity score; WT, wild type.